Low‐dose versus high‐dose methylprednisolone for children with severe Mycoplasma pneumoniae pneumonia (MCMP): Study protocol for a randomized controlled trial

Severe Mycoplasma pneumoniae pneumonia (MPP) may develop with long‐term pulmonary outcomes despite treatment with macrolides. Combined treatment with glucocorticoids can improve this outcome, though the optimal dosage is unknown. The aim of this study was to investigate the effects of low‐ and high‐dose methylprednisolone in reducing the percentage of long‐term pulmonary outcomes for children with severe MPP.

[1]  Le-Xin Wang,et al.  Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. , 2016, Chest.

[2]  Zhimin Chen,et al.  [Effectiveness of methylprednisolone in treatment of children with refractory Mycoplasma pneumoniae pneumonia and its relationship with bronchoalveolar lavage cytokine levels]. , 2015, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[3]  Anami R Patel,et al.  Community-acquired pneumonia requiring hospitalization among U.S. children. , 2015, The New England journal of medicine.

[4]  Sung-Churl Lee,et al.  Early Additional Immune-Modulators for Mycoplasma pneumoniae Pneumonia in Children: An Observation Study , 2014, Infection & chemotherapy.

[5]  Maureen H Diaz,et al.  Investigations of Mycoplasma pneumoniae Infections in the United States: Trends in Molecular Typing and Macrolide Resistance from 2006 to 2013 , 2014, Journal of Clinical Microbiology.

[6]  E. Liu,et al.  Effects of prednisolone on refractory mycoplasma pneumoniae pneumonia in children , 2014, Pediatric pulmonology.

[7]  Jinrong Liu,et al.  [Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children]. , 2014, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[8]  H. Kil,et al.  Effects of Methylprednisolone Pulse Therapy on Refractory Mycoplasma pneumoniae Pneumonia in Children , 2013, Allergy, asthma & immunology research.

[9]  M. Niederman,et al.  Systemic corticosteroids for community‐acquired pneumonia: Reasons for use and lack of benefit on outcome , 2013, Respirology.

[10]  G. Balla,et al.  Efficacy of methylprednisolone in children with severe community acquired pneumonia , 2013, Pediatric pulmonology.

[11]  [Guidelines for management of community acquired pneumonia in children (the revised edition of 2013) (I)]. , 2013, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[12]  Kyung-Yil Lee,et al.  Mycoplasma pneumoniae pneumonia in children , 2012, Korean journal of pediatrics.

[13]  John S. Bradley,et al.  The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  S. Kamiya,et al.  Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone. , 2011, FEMS immunology and medical microbiology.

[15]  Jian-hua Duan,et al.  [Clinical report on 68 cases of refractory mycoplasma pneumoniae pneumonia (RMPP)]. , 2011, Zhonghua shi yan he lin chuang bing du xue za zhi = Zhonghua shiyan he linchuang bingduxue zazhi = Chinese journal of experimental and clinical virology.

[16]  H. Tsutsumi,et al.  Japanese Guidelines for the Management of Respiratory Infectious Diseases in Children 2007 with focus on pneumonia , 2011, Pediatrics international : official journal of the Japan Pediatric Society.

[17]  Jiang Zai-fang.  Analysis of Relevant Factors of Severe Mycoplasma Pneumoniae Pneumonia in Acute Phase in Children , 2011 .

[18]  Hong Zhang,et al.  Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. , 2010, Diagnostic microbiology and infectious disease.

[19]  T. Fukaya,et al.  Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children , 2008, Journal of Infection.

[20]  N. Kim,et al.  Mycoplasma pneumoniae in Korean children: the epidemiology of pneumonia over an 18-year period. , 2008, The Journal of infection.

[21]  T. Horiuchi,et al.  Efficacy of Corticosteroids in the Treatment of Community-Acquired Pneumonia Requiring Hospitalization , 2007, Lung.

[22]  D. Burgner,et al.  Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children , 2006, Pediatric pulmonology.

[23]  M. Matsuoka,et al.  Clinical Evaluation of Macrolide-Resistant Mycoplasma pneumoniae , 2006, Antimicrobial Agents and Chemotherapy.

[24]  J. Cidlowski,et al.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.

[25]  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock , 2003, Current infectious disease reports.

[26]  T. Terano,et al.  Fulminant Mycoplasma pneumoniae pneumonia. , 2001, Internal medicine.

[27]  T. Clemmer,et al.  A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. , 1987, The New England journal of medicine.